13.10
price down icon3.03%   -0.41
after-market Dopo l'orario di chiusura: 12.85 -0.25 -1.91%
loading
Precedente Chiudi:
$13.51
Aprire:
$13.45
Volume 24 ore:
728.41K
Relative Volume:
1.08
Capitalizzazione di mercato:
$715.22M
Reddito:
$8.78M
Utile/perdita netta:
$-104.70M
Rapporto P/E:
-5.5274
EPS:
-2.37
Flusso di cassa netto:
$-82.68M
1 W Prestazione:
-0.91%
1M Prestazione:
+10.92%
6M Prestazione:
+23.35%
1 anno Prestazione:
-10.03%
Intervallo 1D:
Value
$12.55
$13.45
Intervallo di 1 settimana:
Value
$12.26
$14.78
Portata 52W:
Value
$5.35
$16.15

Stoke Therapeutics Inc Stock (STOK) Company Profile

Name
Nome
Stoke Therapeutics Inc
Name
Telefono
781-430-8200
Name
Indirizzo
45 WIGGINS AVENUE, BEDFORD, MA
Name
Dipendente
128
Name
Cinguettio
@stoketx
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
STOK's Discussions on Twitter

Confronta STOK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
STOK
Stoke Therapeutics Inc
13.10 737.60M 8.78M -104.70M -82.68M -2.37
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-18 Iniziato Jefferies Buy
2024-12-20 Iniziato Chardan Capital Markets Buy
2024-10-14 Ripresa Leerink Partners Outperform
2024-03-26 Aggiornamento TD Cowen Market Perform → Outperform
2023-11-20 Ripresa JP Morgan Neutral
2023-07-25 Downgrade TD Cowen Outperform → Market Perform
2023-05-01 Aggiornamento BofA Securities Underperform → Neutral
2023-04-26 Ripresa Canaccord Genuity Buy
2023-01-06 Downgrade BofA Securities Buy → Underperform
2022-10-24 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-01-31 Iniziato Jefferies Buy
2021-12-03 Iniziato BofA Securities Buy
2021-11-22 Aggiornamento JP Morgan Neutral → Overweight
2021-05-18 Iniziato UBS Neutral
2021-05-10 Aggiornamento Wedbush Neutral → Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-02-10 Downgrade Wedbush Outperform → Neutral
2020-12-15 Ripresa H.C. Wainwright Buy
2020-12-11 Reiterato Needham Buy
2020-10-23 Iniziato Cantor Fitzgerald Overweight
2020-09-29 Ripresa JP Morgan Neutral
2020-09-29 Iniziato Needham Buy
2019-12-18 Iniziato Wedbush Outperform
2019-11-12 Iniziato BTIG Research Buy
2019-10-25 Iniziato H.C. Wainwright Buy
2019-07-15 Iniziato Canaccord Genuity Buy
2019-07-15 Iniziato Cowen Outperform
2019-07-15 Iniziato Credit Suisse Outperform
2019-07-15 Iniziato JP Morgan Overweight
Mostra tutto

Stoke Therapeutics Inc Borsa (STOK) Ultime notizie

pulisher
Jul 27, 2025

Is it the right time to buy Stoke Therapeutics Inc. stockExpert guidance for superior capital growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Stoke Therapeutics Inc. stock compared to the marketSuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Stoke Therapeutics Inc. in the next 12 monthsDiscover market opportunities others miss - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Stoke Therapeutics Inc. stock in 2025Explosive trading opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Stoke Therapeutics Inc. generate profit in a changing economyInvest smarter with actionable market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Stoke Therapeutics Inc. stock expected to show significant growthGet daily updates on top-performing stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Stoke Therapeutics Inc. compare to its industry peersBreakout profit opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Stoke Therapeutics Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Stoke Therapeutics Inc. a good long term investmentSuperior return velocity - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Stoke Therapeutics Inc. stockExtraordinary market timing - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Bets Big On Rare Disease Therapies - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Soars 17.02% on Market Optimism - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Stoke Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Stoke Therapeutics Inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 15:57:09 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 13:02:52 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Jefferies Financial Group Begins Coverage on Stoke Therapeutics (NASDAQ:STOK) - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics (STOK): A High-Conviction Buy with Disease-Modifying Potential in Dravet Syndrome - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Jefferies Recommends Stoke Therapeutics (STOK) with a Buy Rating - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Jefferies initiates Stoke Therapeutics stock with Buy rating on epilepsy drug potential - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 11:35:29 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 17, 2025

Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome - TipRanks

Jul 17, 2025

Stoke Therapeutics Inc Azioni (STOK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):